Retatrutide and the Longevity Medicine Framework Zooming out from the regulatory timeline, retatrutide's significance to longevity medicine deserves explicit framing
Recent regulatory developments include increased FDA enforcement actions against supplements making drug-like claims, FTC scrutiny of weight loss advertising focusing on substantiation of efficacy claims, and concern about supplements marketed as alternatives to prescription medications without adequate evidence
Zhang Y, Han J, Wu W, Dang B
It may only be used lawfully within an authorised clinical trial or under a specific MHRA-regulated framework for unlicensed medicines
According to studies conducted in May 2026, the trial involved 2,339 participants who received doses of either 4 mg, 9 mg, 12 mg, or a placebo
State that flatly to yourself before you get your hopes up